Inconsistent results also emerged from studies evaluating the effects of the most widespread treatments for MDD on circulating VEGF levels [61] and the possibility to exploit VEGF levels measured prior to treatment to predict its outcome [62,63]. This evidence concerns the gene VEGFA and major depressive disorder.